Fifth Third Bancorp
LEGN icon

Fifth Third Bancorp’s Legend Biotech LEGN Stock Holding History

Fifth Third Bancorp’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Buy
7,336
+7,017
+2,200% +$189K ﹤0.01% 2574
2026
Q1 		$5.77K Buy
319
+183
+135% +$3.49K ﹤0.01% 3826
2025
Q4 		$2.96K Sell
136
-193
-59% -$5.53K ﹤0.01% 2397
2025
Q3 		$10.7K Buy
329
+53
+19% +$1.96K ﹤0.01% 2122
2025
Q2 		$9.79K Hold
276
– – ﹤0.01% 2017
2025
Q1 		$9.37K Hold
276
– – ﹤0.01% 2026
2024
Q4 		$8.98K Hold
276
– – ﹤0.01% 2005
2024
Q3 		$13.4K Buy
276
+10
+4% +$533 ﹤0.01% 1904
2024
Q2 		$11.8K Buy
266
+49
+23% +$2.26K ﹤0.01% 1879
2024
Q1 		$12.2K Buy
217
+24
+12% +$1.45K ﹤0.01% 1816
2023
Q4 		$11.6K Buy
193
+48
+33% +$3.04K ﹤0.01% 1930
2023
Q3 		$9.74K Buy
145
+71
+96% +$4.93K ﹤0.01% 1963
2023
Q2 		$5.11K Buy
+74
New +$4.83K ﹤0.01% 2187

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Fifth Third Bancorp's LEGN Position: Q2 2026 in Review

Fifth Third Bancorp increased its Legend Biotech (LEGN) stake by 2,200% in Q2 2026, buying an estimated $189K and bringing the position to 7,336 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #2574.

Fifth Third Bancorp first reported a position in LEGN in Q2 2023 and has held it in 13 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Fifth Third Bancorp held 7,336 shares of Legend Biotech worth $212K as of Q2 2026.
  • Fifth Third Bancorp bought 7,017 Legend Biotech shares in Q2 2026, an estimated $189K.
  • Legend Biotech made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2574 holding.
  • Fifth Third Bancorp first reported a position in Legend Biotech in Q2 2023 and has held it in 13 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.